DAFNA Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-106,810
| Closed | -$395K | – | 84 |
|
|
2017
Q4 | $395K | Sell |
106,810
-10,500
| -9% | -$38.8K | 0.21% | 62 |
|
|
2017
Q3 | $480K | Hold |
117,310
| – | – | 0.3% | 55 |
|
|
2017
Q2 | $436K | Sell |
117,310
-67,949
| -37% | -$253K | 0.31% | 55 |
|
|
2017
Q1 | $767K | Buy |
+185,259
| New | +$767K | 0.65% | 46 |
|
|
2016
Q3 | – | Sell |
-29,167
| Closed | -$165K | – | 101 |
|
|
2016
Q2 | $165K | Buy |
+29,167
| New | +$165K | 0.13% | 82 |
|
|
2015
Q4 | – | Sell |
-6,030
| Closed | -$99K | – | 89 |
|
|
2015
Q3 | $99K | Hold |
6,030
| – | – | 0.1% | 79 |
|
|
2015
Q2 | $135K | Buy |
+6,030
| New | +$135K | 0.11% | 69 |
|
|
2014
Q4 | – | Sell |
-35,829
| Closed | -$413K | – | 70 |
|
|
2014
Q3 | $413K | Buy |
+35,829
| New | +$413K | 0.42% | 39 |
|